Bayesian identification of a population compartmental model of C-peptide kinetics

被引:12
作者
Magni, P
Bellazzi, R
Sparacino, G
Cobelli, C
机构
[1] Univ Padua, Dipartimento Elettr & Informat, I-35131 Padua, Italy
[2] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy
关键词
C-peptide; population model; compartmental model; Bayes estimation; Markov chain Monte Carlo; insulin; system identification;
D O I
10.1114/1.1289459
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
When models are used to measure or predict physiological variables and parameters in a given individual, the experiments needed are often complex and costly. A valuable solution for improving their cost effectiveness is represented by population models. A widely used population model in insulin secretion studies is the one proposed by Van Cauter et al. (Diabetes 41:368-377, 1992), which determines the parameters of the two compartment model of C-peptide kinetics in a given individual from the knowledge of his/her age, sex, body surface area, and health condition (i.e., normal, obese, diabetic). This population model was identified from the data of a large training set (more than 200 subjects) via a deterministic approach. This approach, while sound in terms of providing a point estimate of C-peptide kinetic parameters in a given individual, does not provide a measure of their precision. In this paper, by employing the same training set of Van Cauter et al., we show that the identification of the population model into a Bayesian framework (by using Markov chain Monte Carlo) allows, at the individual level, the estimation of point values of the C-peptide kinetic parameters together with their precision. A successful application of the methodology is illustrated in the estimation of C-peptide kinetic parameters of seven subjects (not belonging to the training set used for the identification of the population model) for which reference values were available thanks to an independent identification experiment. (C) 2000 Biomedical Engineering Society. [S0090-6964(00)00907-3].
引用
收藏
页码:812 / 823
页数:12
相关论文
共 27 条
[1]  
BAILAR JC, 1997, NEW ENGL J MED, V337, P1
[2]  
BEAL SL, 1998, NONMEM USERS GUIDE
[3]   Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function [J].
Byrne, MM ;
Sturis, J ;
Sobel, RJ ;
Polonsky, KS .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 270 (04) :E572-E579
[4]  
Carlin B. P., 2001, BAYES EMPIRICAL BAYE
[5]   Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance [J].
Cavaghan, MK ;
Ehrmann, DA ;
Byrne, MM ;
Polonsky, KS .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (03) :530-537
[6]  
Davidian M., 1995, NONLINEAR MODELS REP
[7]   PREHEPATIC INSULIN PRODUCTION IN MAN - KINETIC-ANALYSIS USING PERIPHERAL CONNECTING PEPTIDE BEHAVIOR [J].
EATON, RP ;
ALLEN, RC ;
SCHADE, DS ;
ERICKSON, KM ;
STANDEFER, J .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (03) :520-528
[8]   KINETICS OF HUMAN CONNECTING PEPTIDE IN NORMAL AND DIABETIC SUBJECTS [J].
FABER, OK ;
HAGEN, C ;
BINDER, C ;
MARKUSSEN, J ;
NAITHANI, VK ;
BLIX, PM ;
KUZUYA, H ;
HORWITZ, DL ;
RUBENSTEIN, AH ;
ROSSING, N .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (01) :197-203
[9]  
FERRANNINI E, 1987, Diabetes Metabolism Reviews, V3, P335
[10]   Physiological pharmacokinetic analysis using population modeling and informative prior distributions [J].
Gelman, A ;
Bois, F ;
Jiang, JM .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1996, 91 (436) :1400-1412